Chronic Medication Burden and Complexity for US Patients with Type 2 Diabetes Treated with Glucose-Lowering Agents-Reference-Cited by-同舟云学术

Chronic Medication Burden and Complexity for US Patients with Type 2 Diabetes Treated with Glucose-Lowering Agents

Published:2020-05-23 Issue:7 Volume:11 Page:1513-1525
ISSN:1869-6953
Container-title:Diabetes Therapy
language:en
Short-container-title:Diabetes Ther

Author:

Boye Kristina S.,Mody Reema,Lage Maureen J.^ORCID,Douglas Steven,Patel Hiren

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13300-020-00838-6.pdf

Reference38 articles.

1. Cornell S. Continual evolution of type 2 diabetes: an update on pathophysiology and emerging treatment options. Ther Clin Risk Manag. 2015;11:621–32.

2. Centers for Disease Control and Prevention. Diabetes: about diabetes. US Department of Health & Human Services. Published September 27, 2019. https://www.cdc.gov/diabetes/basics/diabetes.html. Accessed 5 Feb 2020.

3. American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2019. Diabetes Care. 2020;42:S98–S110.

4. Iglay K, Hannachi H, Joseph Howie P, et al. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016;32:1243–52.

5. Kirkman MS, Rowan-Martin MT, Levin R, et al. Determinants of adherence to diabetes medications: findings from a large pharmacy claims database. Diabetes Care. 2015;38(4):604–9.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test;Pharmacological Reviews;2024-08-09

2. Reliability and validity of the Turkish version of the medication practical barriers to adherence questionnaire in patients with chronic diseases;European Journal of Clinical Pharmacology;2024-08-07

3. Prescription medication use among patients with type 2 diabetes in the United States: 1999–2020;Diabetes, Obesity and Metabolism;2024-05-02

4. Relationship Between Diet Quality and Glucose-Lowering Medication Intensity Among Adults With Type 2 Diabetes: Results From the CARTaGENE Cohort;CJC Open;2024-01

5. Metformin, Empagliflozin, and Their Combination Modulate Ex-Vivo Macrophage Inflammatory Gene Expression;International Journal of Molecular Sciences;2023-03-01